Tuberculosis in Rural and Malnourished Populations
Launched by UNIVERSITY OF VIRGINIA · May 6, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve the screening and prevention of tuberculosis (TB) in households of people who have recently been diagnosed with the disease in rural Tanzania. TB is a serious health issue in this region, and many people remain undiagnosed. The researchers want to see if offering financial support, called conditional cash transfers, can help more families get screened for TB. They will also look at the nutrition status of these families to understand how undernutrition might affect their risk of developing active TB.
To participate in this study, individuals must be diagnosed with drug-sensitive pulmonary TB and start treatment within two months. They should live near the Haydom Lutheran Hospital and agree to be part of the study. If you join, you can expect visits to your home where researchers will help with TB screenings for everyone in your household and measure things like height and weight to assess nutrition. The study will last for three years, during which families will be monitored to see how many develop TB and how effective the financial support is in encouraging screenings. This research aims to find ways to better support high-risk communities in fighting TB.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Index person/people diagnosed with drug sensitive pulmonary tuberculosis disease (PWTB) and starting TB treatment within 2 months of enrollment, of any age.
- • Index PWTB are eligible if they reside within the catchment area of Haydom Lutheran Hospital (HLH), and
- • Index PWTB intend to receive TB care at a participating study site.
- • Index PWTB (or their parent or guardian if index PWTB are \<18 years) and head of household (if different from index PWTB) are able and willing to provide informed consent.
- Exclusion Criteria:
- • Inability to provide informed consent, or assent when applicable.
- • Residing or receiving TB care outside of the catchment area of study sites
- • Prior completion of TB screening procedures for all household members.
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Haydom, Manyara, Tanzania
Patients applied
Trial Officials
Tania Thomas, MD MPH
Principal Investigator
University of Virginia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported